The Use of a 3.15%CHG/70%IPA Disinfection for Sustained CLABSI Reduction in a Large Urban Teaching Facility

The Use of a 3.15%CHG/70%IPA Disinfection for Sustained CLABSI Reduction in a Large Urban Teaching Facility

 

The abstract, which was presented at the AVA Annual Conference, September 15-18, 2018, in Columbus, OH, examined the impact of 3.15% CHG/70% IPA swab on CLABSI reduction.

Results: Prevantics® Device Swab trial resulted in a statistically significant reduction in CLABSIs.

Prevantics Device Swab Abstract AVA 2018

Additional Clinical Resources

View All